Session: Antimicrobial Use in Children (IDWeek 2013)

Thursday, October 3, 2013: 12:30 PM-2:00 PM

Room: The Moscone Center: Poster Hall C

Tracks: Pediatric ID

Presentations:

156	Linezolid-Associated Thrombocytopenia in Children with Renal Impairment Heather Deyoung, PharmD Candidate ; Sara Jones, PharmD Candidate ; Kristen Nichols, PharmD, BCPS ; Elaine Cox, MD ; Chad Knoderer, PharmD Posters Knoderer_Linezolid outcomes_092613.pdf (1.9 MB)

157

Assessing the Impact of a Linezolid Clinical Decision Support Tool on Linezolid Use at a Pediatric Academic Medical Center
Alexander Kay, MD ; Jenny Li, PharmD ; John Tamaresis, PhD, MS ; Laurale Dyner, MD ; Roshni Mathew, MD ; Natalie Pageler, MD ; Betty Lee, PharmD ; Kathleen Gutierrez, MD

Posters

idsafinalv3.pdf (534.0 kB)

158

The Use and Safety of Ciprofloxacin in Korean Children: A Retrospective Multicenter Study
Soo-Han Choi, MD ; Yanghyun Kim, RN ; Eun Young Kim, PhD ; Wonku Kang, PhD ; Byung-Kee Lee, MD ; Soo Jin Kim, MD ; Eun Hwa Choi, MD, PhD ; Hoan Jong Lee, MD, PhD, FIDSA ; Ki Hwan Kim, MD, PhD ; Dong Soo Kim, MD, PhD ; Byung Wook Eun, MD, PhD ; Dae Sun Jo, MD, PhD ; Jong-Hyun Kim, MD, PhD ; Su Eun Park, MD, PhD ; Yae-Jean Kim, MD, PhD

Posters

IDWeek 2013_Poster No.158.pdf (224.3 kB)

159	Vancomyin Dosing and Serum Trough Levels in Hospitalized Children Serra Akyar, BA ; Jennifer Duchon, MDCM, MPH ; Sameer Patel, MD, MPH Posters Vancomycin Dosing and Serum Trough Levels In Hospitalized Children.IDWeek.42027.UPLOAD.pdf (474.8 kB)

160	Evaluation of Vancomycin Dosing in Infants Less than 1200 Grams and Greater than 30 Days Old Cassandra Vandevoorde, PharmD ; Kelly Kopec, PharmD Posters ACHvanco-infant-PosterpngFinal(1).pdf (495.5 kB)

161	Overuse of Vancomycin in a Neonatal Intensive Care Unit Galit Holzmann-Pazgal, MD ; Amir Khan, M.D. ; Christine Domonoske, PharmD ; Eric Eichenwald, MD Posters IDweek2013 final.pdf (231.1 kB)

162	Vancomycin Loading Dose in Pediatric Patients Receiving Intermittent Vancomycin Dosing Allison H. Bartlett, MD, MS ; Danielle Brown-Alm, PharmD, BCPS ; Emily Landon, MD ; Benjamin D. Brielmaier, PharmD ; Palak H. Bhagat, PharmD, BCPS Posters IDWeek_2013 - Vanco LD_final_three.pdf (682.0 kB)

163	Outcomes with Extended-Infusion Piperacillin/Tazobactam in Pediatrics Katie Andricopulos, PharmD ; Kristen Nichols, PharmD, BCPS ; Ashley Crumby, PharmD, AAHIVP ; Elaine Cox, MD ; Chad Knoderer, PharmD Posters Nichols_Piptazo outcomes_092613.pdf (2.0 MB)

164

Ceftaroline Activity Tested against Bacterial Isolates from Pediatric Patients: Results from the Assessing Worldwide Antimicrobial Resistance and Evaluation (AWARE) Program for the United States (2011-2012)
Helio Sader ; Robert Flamm ; Ronald Jones, MD

Posters

IDWEEK 2013 Ceftaroline PEDS 164.pdf (132.4 kB)

165

In vitro Activity of Ceftaroline and 11 Comparators against Pediatric Staphylococcus aureus and Pneumococcal isolates from 2007-2013, Focusing on Invasive and Antibiotic Resistant Strains
Christopher Harrison, M.D. ; R. Scott Duncan, Ph.D. ; Douglas Swanson, MD ; Gordon Stout ; Charles Woods, MD, MS, FIDSA, FSHEA ; Rangaraj Selvarangan, PhD

Posters

IDSA-Ceftaroline-Poster-v09202013 cjh 8d 20X40 RSD.pdf (143.6 kB)

166

A Comparison of Amphotericin B Deoxycholate (D-AMB) versus Liposomal Amphotericin B (L-AMB) in Neonates: Is Newer Better?
Siyun Liao, Pharm.D., Ph.D. ; Zahra Kassamali, PharmD ; Donna Kraus, Pharm.D. ; Robert Glowacki, PharmD ; Larry H. Danziger, Pharm.D.

Posters

ID 2013 poster ampho peds simplify 09192013.pdf (199.9 kB)

167	Voriconazole (VCZ) Dosing in Pediatric Patients Pavel Prusakov, PharmD ; Reginald King, PharmD, BCOP ; Palak H. Bhagat, PharmD, BCPS ; Allison H. Bartlett, MD, MS ; Danielle Brown-Alm, PharmD, BCPS Posters Pavel_vori_final.pdf (411.3 kB)

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Poster Abstract Session

<< Previous Session | Next Session >>